Evidence map›Paper›PMID 27611229›Full record

ArticleCell cycle (Georgetown, Tex.)2016

p53 controls CDC7 levels to reinforce G1 cell cycle arrest upon genotoxic stress.

Slavica Tudzarova, Paul Mulholland, Ayona Dey, Kai Stoeber, Andrei L Okorokov, Gareth H Williams

Open access · hybridAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.6field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Upregulation ofBioMed research international · 2021
    Article
  6. Ethanol Extracts ofJournal of immunology research · 2021
    Article
  7. Frontiers in cell and developmental biology · 2021
    Article
  8. Article
  9. Coordination of miR-192 and miR-22 in p53-Mediated Cell Fate Decision.International journal of molecular sciences · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. A novel p53-Cdc7 link induced by genotoxic stress.Cell cycle (Georgetown, Tex.) · 2017
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Slavica Tudzarovaa Wolfson Institute for Biomedical Research, Division of Medicine, University College London , London , UK.
Paul Mulhollandc Department of Pathology , UCL Cancer Institute, University College London , London , UK.
Ayona Deya Wolfson Institute for Biomedical Research, Division of Medicine, University College London , London , UK.
Kai Stoeberc Department of Pathology , UCL Cancer Institute, University College London , London , UK.
Andrei L Okorokova Wolfson Institute for Biomedical Research, Division of Medicine, University College London , London , UK.
Gareth H Williamsc Department of Pathology , UCL Cancer Institute, University College London , London , UK.
University College London · GBWolfson Foundation · GB

Funding

Biotechnology and Biological Sciences Research Council BB/E019862/1
6 · The paper itself

Abstract

DNA replication initiation is a key event in the cell cycle, which is dependent on 2 kinases - CDK2 and CDC7. Here we report a novel mechanism in which p53 induces G1 checkpoint and cell cycle arrest by downregulating CDC7 kinase in response to genotoxic stress. We demonstrate that p53 controls CDC7 stability post-transcriptionally via miR-192/215 and post-translationally via Fbxw7β E3 ubiquitin ligase. The p53-dependent pathway of CDC7 downregulation is interlinked with the p53-p21-CDK2 pathway, as p21-mediated inhibition of CDK2-dependent phosphorylation of CDC7 on Thr376 is required for GSK3ß-phosphorylation and Fbxw7ß-dependent degradation of CDC7. Notably, sustained oncogenic high levels of active CDC7 exert a negative feedback onto p53, leading to unrestrained S-phase progression and accumulation of DNA damage. Thus, p53-dependent control of CDC7 levels is essential for blocking G1/S cell-cycle transition upon genotoxic stress, thereby safeguarding the genome from instability and thus representing a novel general stress response.

Indexed as

DNA DamageG1 Phase Cell Cycle CheckpointsCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21Down-RegulationFeedback, PhysiologicalGlycogen Synthase Kinase 3 betaHCT116 CellsHumansMicroRNAsProtein Serine-Threonine KinasesProteolysisRNA, MessengerTransfectionTumor Suppressor Protein p53Ubiquitin-Protein LigasesCDC7 protein, humanCell Cycle ProteinsCyclin-Dependent Kinase Inhibitor p21Glycogen Synthase Kinase 3 betaMicroRNAsProtein Serine-Threonine KinasesRNA, MessengerTumor Suppressor Protein p53Ubiquitin-Protein LigasesCDC7CDK2cell cycleDNA damageDNA replicationFbxw7βGSK3βmiRNA-192/215p21p53protein degradation

Identifiers

PMID27611229
PMCPMC5105930
OpenAlexW2512602372

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.